Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion.
Chronic intestinal pseudo-obstruction is a life-threatening condition of unknown pathogenic mechanisms. Chronic intestinal pseudo-obstruction can be a feature of mitochondrial disorders, such as mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), a rare autosomal-recessive syndrome, resulting from mutations in the thymidine phosphorylase gene. MNGIE patients show elevated circulating levels of thymidine and deoxyuridine, and accumulate somatic mitochondrial DNA (mtDNA) defects. The present study aimed to clarify the molecular basis of chronic intestinal pseudo-obstruction in MNGIE. Using laser capture microdissection, we correlated the histopathological features with mtDNA defects in different tissues from the gastrointestinal wall of five MNGIE and ten control patients. We found mtDNA depletion, mitochondrial proliferation, and smooth cell atrophy in the external layer of the muscularis propria, in the stomach and in the small intestine of MNGIE patients. In controls, the lowest amounts of mtDNA were present at the same sites, as compared with other layers of the gastrointestinal wall. We also observed mitochondrial proliferation and mtDNA depletion in small vessel endothelial and smooth muscle cells. Thus, visceral mitochondrial myopathy likely causes gastrointestinal dysmotility in MNGIE patients. The low baseline abundance of mtDNA molecules may predispose smooth muscle cells of the muscularis propria external layer to the toxic effects of thymidine and deoxyuridine, and exposure to high circulating levels of nucleosides may account for the mtDNA depletion observed in the small vessel wall.
Giordano
Carla
C
Dipartimento di Medicina Sperimentale, Sapienza, Università di Roma, Roma, Italy.
Sebastiani
Mariangela
M
De Giorgio
Roberto
R
Travaglini
Claudia
C
Tancredi
Andrea
A
Valentino
Maria Lucia
ML
Bellan
Marzio
M
Cossarizza
Andrea
A
Hirano
Michio
M
d'Amati
Giulia
G
Carelli
Valerio
V
D000328:Adult; D004272:DNA, Mitochondrial / Q000235:genetics*; D042783:Endothelial Cells / Q000473:pathology; D004947:Esophagus / Q000473:pathology; D005260:Female; D005767:Gastrointestinal Diseases / Q000473:pathology / Q000503:physiopathology*; D005769:Gastrointestinal Motility / Q000502:physiology*; D041981:Gastrointestinal Tract / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008297:Male; D042282:Microdissection; D017237:Mitochondrial Encephalomyopathies / Q000473:pathology / Q000503:physiopathology*; D032389:Myocytes, Smooth Muscle / Q000473:pathology; D017354:Point Mutation / Q000235:genetics; D017384:Sequence Deletion
D004272:DNA, Mitochondrial
J Biol Chem. 2003 Nov 7;278(45):43893-6
13679382
Am J Gastroenterol. 2003 Mar;98(3):618-24
12650797
J Biol Chem. 2005 Jul 1;280(26):24472-80
15878850
J Clin Invest. 2003 Jun;111(12):1913-21
12813027
Arterioscler Thromb Vasc Biol. 2007 May;27(5):1004-13
17332491
N Engl J Med. 2003 Jun 26;348(26):2656-68
12826641
AIDS. 2005 Oct 14;19(15):1627-33
16184032
Ann Neurol. 2000 Jun;47(6):792-800
10852545
Hum Mol Genet. 2004 Jan 1;13(1):91-101
14613972
Anal Biochem. 2007 Nov 1;370(1):127-9
17662684
Gastroenterology. 2006 Mar;130(3):893-901
16530527
J Biol Chem. 2002 Feb 8;277(6):4128-33
11733540
J Biol Chem. 1999 Aug 13;274(33):22968-76
10438462
FEBS Lett. 2007 Jul 24;581(18):3410-4
17612528
Br J Pharmacol. 2004 Sep;143(1):202-14
15289294
Neurogastroenterol Motil. 2007 Jun;19(6):440-52
17564625
Ann Neurol. 2004 Dec;56(6):881-6
15562405
Neurology. 2006 Oct 24;67(8):1458-60
16971696
Gastroenterology. 2006 Feb;130(2 Suppl 1):S29-36
16473068
Gut. 2004 Nov;53(11):1549-52
15479666
Basic Res Cardiol. 1985 Sep-Oct;80(5):459-74
3935101
J Biol Chem. 2006 Aug 11;281(32):22720-8
16774911